Contact: B.D. Colen
Caption: Kevin Eggan, a principal faculty member of the Harvard Stem Cell Institute and Professor in Harvard's Department of Stem Cell and Regenerative Biology is credited with first moving ALS -- Lou Gehrig's disease into a laboratory dish in 2008, paving the way for the study of treatments using human cells.
Credit: B.D. Colen/Harvard University
Usage Restrictions: The image may only be used with appropriate credit.
Related news release: Patient stem cells help identify common problem in ALS